Revelation Biosciences, Inc. Warrants Due 01/14/2027 (REVBW)
NCM · · CUSIP 76135L119
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for REVBW and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
76135L119 (prev. 716421110 )
Previous Symbol
PAICW (changed 1/14/2022)
Previous Name
Petra Acquisition, Inc.
Parent Company
Revelation Biosciences, Inc. (REVB)
Business: Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of innate immune system therapeutics and diagnostics for the prevention and treatment of disease. The Company has several product candidates in development.
Notes: Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share. Each warrant will become exercisable on the later of 30 days after the completion of an initial business combination or 12 months from the closing of the offering and will expire on the fifth anniversary of our completion of an initial business combination, or earlier upon redemption or liquidation.

Company Contact

CEO
James Rolke
CFO
Chester Zygmont, III
Headquarters
4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122
Phone
650-800-3717
Investor Relations
Sandra Vedrick · 650-800-3717 · svedrick@revbiosciences.com
General Email
info@revbiosciences.com
SEC EDGAR Filings
View filings »